According to MHT, BioAnalytix LLC, a spin-off from the Barnett Institute of Chemical and Biological Analysis, raised seed funding of $858,000 from 11 investors, according to a federal filing.
The company analyzes and characterizes large-molecular biologic drugs and biosimilars Kirtland Poss, co-founder and CEO of BioAnalytix, said that the company was founded by itself and three others in recent months: Robert Garnick, consultant with Lone Mountain Biotechnology and Medical Devices Inc. In Las Vegas; Barry Karger, director of the Barnett Institute; and Billy Wu, senior analyst at Barnett and formerly Genentech.
Please note that this piece of work originally appeared in English at https://www.vcnewsdaily.com/BioAnalytix/venture-funding.php. As Investocracy aims to bring global startup news and updates in both English and Japanese to you, it’s important that we attribute original source to you. If you have any questions/concerns please write to us at contact@investocracy.co
Singapore has always had a progressive healthcare system with prioritizing innovative solutions to the existing…
A Ponzi scheme is a fraudulent investment scheme that aims to give its investors high…
According to the Global Prop tech Survey, 2019 published by KPMG one of the key…
In April 2016, the world witnessed one of the biggest information leaks in history, consisting…
Silent Eight a global technology company that helps combat money laundering and terrorism financing using…
Indian startup Gully Network Retail Pvt Ltd, a retail-tech startup focused on providing services to…
Leave a Comment